Probiotix Health (FRA:X90) EBITDA Margin %: -75.99% (As of Dec. 2025)


What is Probiotix Health EBITDA Margin %?

Probiotix Health FRA:X90 EBITDA Margin % is -75.99% as of Dec. 2025. The stock has 2 warning signs investors should review. Among 944 Biotechnology companies, Probiotix Health ranks better than 53.39% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Probiotix Health's EBITDA for the six months ended in Dec. 2025 was €-1.21 Mil. Probiotix Health's Revenue for the six months ended in Dec. 2025 was €1.59 Mil. Therefore, Probiotix Health's EBITDA margin for the quarter that ended in Dec. 2025 was -75.99%.

Probiotix Health  (FRA:X90) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Probiotix Health EBITDA Margin % Related Terms

Probiotix Health EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Probiotix Health's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Probiotix Health EBITDA Margin % Chart

Probiotix Health Annual Data
Trend Dec18 Dec19 Dec20 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial 10.69 0.00 -39.80 -40.96 -43.29

Probiotix Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.22 -24.05 -60.34 -9.55 -75.99

FRA:X90 vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, Probiotix Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Probiotix Health EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Probiotix Health's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Probiotix Health's EBITDA Margin % falls into.


Probiotix Health EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Probiotix Health's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-1.352/3.123
=-43.29 %

Probiotix Health's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-1.206/1.587
=-75.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -75.99% mean?
Probiotix Health (FRA:X90) has a EBITDA Margin % of -75.99% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Probiotix Health and its competitors. According to the industry distribution chart, Probiotix Health ranks #440 out of 944 companies in the Biotechnology industry, placing it in the top 46.6%.
Is Probiotix Health's EBITDA Margin % too high?
Probiotix Health's current EBITDA Margin % is -75.99%. Based on the distribution chart, Probiotix Health ranks #440 out of 944 companies in the Biotechnology industry, which is above the industry midpoint.
How does Probiotix Health's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Probiotix Health ranks #440 out of 944 companies for EBITDA Margin %. This puts Probiotix Health in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Probiotix Health and its competitors. Probiotix Health's current EBITDA Margin % is -75.99%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Probiotix Health stock overvalued right now?
Probiotix Health (FRA:X90) has a current EBITDA Margin % of -75.99%. The stock's GF Value™ is €0.08, compared to a current price of €0.07 — trading 7.5% below its estimated fair value. The current EBITDA Margin % is -75.99%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Probiotix Health (FRA:X90), the current EBITDA Margin % is -75.99% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Probiotix Health Business Description

Other Exchanges PBX:UK
Address Nostell Business Estate, First Floor Zucchi Suite, Wakefield, GBR, WF4 1AB
Probiotix Health PLC is a life sciences company that develops probiotics to tackle cardiovascular disease and other lifestyle conditions that are affecting growing numbers of people across the world. The company has one class of business, in three geographical areas, being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry. Its geographical segments include the United Kingdom, the United States, and the Rest of the World. It generates the majority of its revenue from the United States.